It is with great excitement that we announce that Nordic Capital has entered into a definitive agreement to acquire ArisGlobal. Six months ago, ArisGlobal set out on a mission to find a large investor to support our rapid growth moving forward. This was a carefully administered process that required us to engage and vet a number of top healthcare investors as we searched for the best partner for ArisGlobal. Today, I am pleased to inform you that we have found the right one.
Our firm traces its roots back to 1987, when our founder, Deepak Abbhi, pioneered the development of a first-in-industry adverse event management system that would help life sciences firms automate their mission critical global pharmacovigilance functions for patient safety and regulatory compliance. Over these 32 years, we have built a sustainable and growing business that thrives on its partnerships with many life sciences companies and regulatory agencies. These customer relationships, some lasting decades, have allowed us to become a leading healthcare technology company with over 1200 employees across an expansive global footprint.
Today, we are embarking on a new chapter that will accelerate our ability to achieve our mission of being the leading provider of SaaS solutions for pharmacovigilance, regulatory affairs, medical affairs and clinical development. As our two companies began joint discussions, the possibilities of what we might do with Nordic Capital became very compelling. Nordic Capital, through their investment in ERT, a leading clinical technology solutions provider, has a proven life sciences track record and we share a closely aligned vision for the future of the industry. The acquisition gives us immediate access to deep resources and expert guidance that will help us in our journey. For all the reasons mentioned above, our founder, myself, our Board of Directors, and management team all came to believe that the best way – the most exciting way forward for ArisGlobal and our clients – was to join forces with Nordic Capital.
Moving forward, our management team, including myself, will remain dedicated to ArisGlobal full-time and will continue to manage the company as a standalone entity for the years ahead. Our goal is to continue our strong growth through product innovation, customer satisfaction and industry thought leadership. We are confident that the resources and expertise provided by Nordic Capital will help us achieve this. We feel that you, as our valued customer, will benefit from this partnership as well.
Our unwavering focus on your needs will continue to be the core of who we are as a company. It drives the development of our LifeSphere platform and it fuels our passion for becoming the premier innovative technology company in the world.
I am more excited than ever about the future for the ArisGlobal team and our customers.
President and CEO